DF Dent & Co’s GSK GSK Stock Holding History

DF Dent & Co’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,050	Closed	-$238K	–	208
2019 Q4	$238K	Hold	4,050	–	–	﹤0.01%	204
2019 Q3	$216K	Buy	+4,050	New	+$208K	﹤0.01%	204

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

DF Dent & Co's GSK Position: Q1 2020 in Review

DF Dent & Co sold out of GSK (GSK) in Q1 2020, closing a stake of 4,050 shares — an estimated $238K sold.

DF Dent & Co first reported a position in GSK in Q3 2019 and held it in 2 quarters. The position peaked at $238K in Q4 2019. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

DF Dent & Co reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
DF Dent & Co sold 4,050 GSK shares in Q1 2020, an estimated $238K.
DF Dent & Co first reported a position in GSK in Q3 2019 and held it in 2 quarters.
DF Dent & Co's GSK position peaked at $238K in Q4 2019.
817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on DF Dent & Co's 13F filing for Q1 2020, filed 15 May 2020.